Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Hoon Lee

Showing results (241-250 of 513) with videos related to

Pageof 52
Sort By:
Oncology|August 11, 2011
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profilesHyo Song Kim, Min Hee Hong, Kiyeol Kim, et al.
Cancer Research and Treatment|July 28, 2018
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in KoreaSeonggyu Byeon, Youjin Kim, Sung Won Lim, et al.
Iscience|March 30, 2026
Sex-specific prognostic value of triceps skinfold thickness and albumin in pancreatic cancerYoung Hoon Choi, Sang Ah Chi, Kyunga Kim, et al.
Leukemia & Lymphoma|May 19, 2011
Clinical dissection of multicentric Castleman diseaseDong-Yeop Shin, Yoon Kyung Jeon, Yong-Sang Hong, et al.
Cancer Research and Treatment|February 18, 2015
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR MutationsSehhoon Park, Bhumsuk Keam, Se Hyun Kim, et al.
Cancer Research and Treatment|March 19, 2026
Phase II Efficacy and Safety of Pembrolizumab with Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients with Untreated, Asymptomatic Brain Metastasis (PHOEBS)Junkyu Kim, Miran Han, Jinyong Kim, et al.
Scientific Reports|November 5, 2020
Regulatory (FoxP3<sup>+</sup>) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancerJiae Koh, Joon Young Hur, Kyoung Young Lee, et al.
Journal of Neuro-Oncology|September 11, 2014
Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imagingSeunghyun Lee, Seung Hong Choi, Inseon Ryoo, et al.
Plos One|November 25, 2014
Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imagingJae Hyun Kim, Seung Hong Choi, Inseon Ryoo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR MutationBhumsuk Keam, Soo Jin Lee, Tae Min Kim, et al.
Pageof 52

Showing results (241-250 of 513) with videos related to

Sort By:
Pageof 52
Oncology|August 11, 2011
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profilesHyo Song Kim, Min Hee Hong, Kiyeol Kim, et al.
Cancer Research and Treatment|July 28, 2018
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in KoreaSeonggyu Byeon, Youjin Kim, Sung Won Lim, et al.
Iscience|March 30, 2026
Sex-specific prognostic value of triceps skinfold thickness and albumin in pancreatic cancerYoung Hoon Choi, Sang Ah Chi, Kyunga Kim, et al.
Leukemia & Lymphoma|May 19, 2011
Clinical dissection of multicentric Castleman diseaseDong-Yeop Shin, Yoon Kyung Jeon, Yong-Sang Hong, et al.
Cancer Research and Treatment|February 18, 2015
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR MutationsSehhoon Park, Bhumsuk Keam, Se Hyun Kim, et al.
Cancer Research and Treatment|March 19, 2026
Phase II Efficacy and Safety of Pembrolizumab with Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients with Untreated, Asymptomatic Brain Metastasis (PHOEBS)Junkyu Kim, Miran Han, Jinyong Kim, et al.
Scientific Reports|November 5, 2020
Regulatory (FoxP3<sup>+</sup>) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancerJiae Koh, Joon Young Hur, Kyoung Young Lee, et al.
Journal of Neuro-Oncology|September 11, 2014
Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imagingSeunghyun Lee, Seung Hong Choi, Inseon Ryoo, et al.
Plos One|November 25, 2014
Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imagingJae Hyun Kim, Seung Hong Choi, Inseon Ryoo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR MutationBhumsuk Keam, Soo Jin Lee, Tae Min Kim, et al.
Pageof 52